Form 4: Schwab Director Carolyn Schwab-Pomerantz Executes Stock Option and Sells Shares
SEC Form 4 Filing
Director Carolyn Schwab-Pomerantz exercised stock options and sold shares of Schwab (SCHW) on April 18th and 19th, 2024, according to a Form 4 filing with the SEC.
Summary
- Carolyn Schwab-Pomerantz, a director of Schwab, executed a nonqualified stock option on April 18, 2024, acquiring 7,482 shares of common stock at a price of $28.44 per share.
- On the same day, she contributed these 7,482 shares to a revocable trust.
- Also on April 18, 2024, she sold 7,482 shares at a weighted average price of $73.4653, with individual transactions ranging from $73.2701 to $73.585.
- On April 19, 2024, she sold an additional 5,400 shares at a weighted average price of $73.1671 (ranging from $72.88 to $73.42) and 3,600 shares at a weighted average price of $73.1572 (ranging from $72.88 to $73.41) pursuant to a 10b5-1 trading plan.
- Following these transactions, Schwab-Pomerantz directly owns 6,353 shares and indirectly owns 1,713,998.6599 shares through a trust, 577,857 shares through her spouse as trustee, and 2,798 shares through an LLC.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports transactions. The existence of a 10b5-1 plan suggests pre-planned sales, reducing the impact of the sales.
Industry Context
Insider transactions are routinely monitored by investors as they can provide insights into a company's prospects, although they don't always indicate a definitive trend. In this case, the transactions are partially governed by a pre-arranged trading plan.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the potential dilution from option exercises and the selling pressure from the share sales.
- However, the existence of a pre-arranged trading plan mitigates concerns about opportunistic trading.
Key Dates
| Date | Description |
|---|---|
| 11/03/2015 | Option vesting start date |
| 11/10/2023 | Adoption date of Rule 10b5-1 trading plan |
| 04/18/2024 | Date of option exercise and initial share sales |
| 04/19/2024 | Date of subsequent share sales |
| 11/03/2024 | Option expiration date |
| 04/22/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.